MRK · NYSE · Drug Manufacturers - General

Merck

Develops oncology medicines, vaccines, cardiopulmonary therapies, and animal-health products worldwide.

$148.19
After-hours close−0.12 (−0.08%)
At close$148.31(−0.82%)
DateEstimateReportedSurprise
Oct 2026$2.22
Aug 2026−$0.27−$0.13+51.9%
Apr 2026−$1.47−$1.28+12.9%
Feb 2026$2.01$2.04+1.5%
Oct 2025$2.36$2.58+9.3%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Jul 2025
Apr 2025
Feb 2025
Oct 2024
Jul 2024
Apr 2024
Feb 2024
Oct 2023
Aug 2023
Apr 2023
Feb 2023
Oct 2022
Jul 2022
Apr 2022
Feb 2022
Oct 2021
Jul 2021
Apr 2021
Feb 2021
Oct 2020
Jul 2020
Apr 2020
Feb 2020
Oct 2019
Jul 2019
Apr 2019
Feb 2019
Oct 2018
Jul 2018
May 2018
Feb 2018
Oct 2017
Jul 2017
May 2017
Feb 2017
Oct 2016
Jul 2016
May 2016
Feb 2016
Oct 2015
Jul 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Oct 29, 2026$2.22$17.31B
Aug 4, 2026−$0.27−$0.13+51.9%$16.37B$16.61B+1.5%
Apr 30, 2026−$1.47−$1.28+12.9%$15.85B$16.29B+2.8%
Feb 3, 2026$2.01$2.04+1.5%$16.20B$16.40B+1.2%
Oct 30, 2025$2.36$2.58+9.3%$16.98B$17.28B+1.8%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Jul 29, 2025
Apr 24, 2025
Feb 4, 2025
Oct 31, 2024
Jul 30, 2024
Apr 25, 2024
Feb 1, 2024
Oct 26, 2023
Aug 1, 2023
Apr 27, 2023
Feb 2, 2023
Oct 27, 2022
Jul 28, 2022
Apr 28, 2022
Feb 3, 2022
Oct 28, 2021
Jul 29, 2021
Apr 29, 2021
Feb 4, 2021
Oct 27, 2020
Jul 31, 2020
Apr 28, 2020
Feb 5, 2020
Oct 29, 2019
Jul 30, 2019
Apr 30, 2019
Feb 1, 2019
Oct 25, 2018
Jul 27, 2018
May 1, 2018
Feb 2, 2018
Oct 27, 2017
Jul 28, 2017
May 2, 2017
Feb 2, 2017
Oct 25, 2016
Jul 29, 2016
May 5, 2016
Feb 3, 2016
Oct 27, 2015
Jul 28, 2015